Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages

  Jones, Michelle R ^a   Chazenbalk, Gregorio ^a,b   Xu, Ning ^a   Chua, Angela K ^a   Eigler, Tamar ^a   Mengesha, Emebet ^a   Chen, Yen Hao ^a,e   Lee, Jung Min ^a   Pall, Marita ^a   Li, Xiaohui ^a   Chen, Yii Der I ^a   Taylor, Kent D ^a   Mathur, Ruchi ^a,b   Krauss, Ronald M ^c   Rotter, Jerome I ^a,b   Legro, Richard S ^d   Azziz, Ricardo ^a,b,e   Goodarzi, Mark O ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN FOS;

ADIPOSE TISSUE; ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG GENE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; ONCOGENE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOSE TISSUE; ADULT; BLOTTING, WESTERN; BODY MASS INDEX; COHORT STUDIES; DNA; DNA REPLICATION; FEMALE; GENE EXPRESSION; GENES, FOS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; LINKAGE DISEQUILIBRIUM; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT;

MURINAE;

EID: 84866153377     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2153     Document Type: Article

References (40)

1. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R 2011 Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219-231
2. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN 2006 Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:48-53 (Pubitemid 43069116)
3. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ 2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93:1276-1284 (Pubitemid 351519721)
4. Goodarzi MO 2008 Looking for polycystic ovary syndrome genes: rational and best strategy. Semin Reprod Med 26:5-13
5. Jansen E, Laven JS, Dommerholt HB, Polman J, van Rijt C, van den Hurk C, Westland J, Mosselman S, Fauser BC 2004 Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol 18:3050-3063 (Pubitemid 39577925)
6. Jones MR, Chua A, Chen YD, Li X, Krauss RM, Rotter JI, Legro RS, Azziz R, Goodarzi MO 2011 Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome. PLoS One 6:e20120
7. Kenigsberg S, Bentov Y, Chalifa-Caspi V, Potashnik G, Ofir R, Birk OS 2009 Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol Hum Reprod 15:89-103
8. Wood JR, Dumesic DA, Abbott DH, Strauss 3rd JF 2007 Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 92:705-713
9. Ciaraldi TP 2000 Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. J Pediatr Endocrinol Metab 13(Suppl 5):1291-1293
10. Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR 2009 Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metab 94:157-163
11. Beshay VE, Havelock JC, Sirianni R, Ye P, Suzuki T, Rainey WE, Carr BR 2007 The mechanism for protein kinase C inhibition of androgen production and 17α-hydroxylase expression in a theca cell tumor model. J Clin Endocrinol Metab 92:4802-4809 (Pubitemid 350223463)
12. Patel SS, Beshay VE, Escobar JC, Suzuki T, Carr BR 2009 Molecular mechanism for repression of 17α-hydroxylase expression and androstenedione production in granulosa cells. J Clin Endocrinol Metab 94:5163-5168
13. Chazenbalk G, Chen YH, Heneidi S, Lee JM, Pall M, Chen YDI, Azziz R 2012 Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. J Clin Endocrinol Metab 97:E765-E770
14. Goodarzi MO, Antoine HJ, Pall M, Cui J, Guo X, Azziz R 2007 Preliminary evidence of glycogen synthase kinase 3β as a genetic determinant of polycystic ovary syndrome. Fertil Steril 87:1473-1476 (Pubitemid 46829128)
15. Zawadzki J, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 377-384
16. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749 (Pubitemid 38766360)
17. Yuan JS, Reed A, Chen F, Stewart Jr CN 2006 Statistical analysis of real-time PCR data. BMC Bioinformatics 7:85
18. Sasaki T, Kojima H, Kishimoto R, Ikeda A, Kunimoto H, Nakajima K 2006 Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol Cell 24:63-75 (Pubitemid 44466681)
19. Legro RS, Driscoll D, Strauss 3rd JF, Fox J, Dunaif A 1998 Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95:14956-14960 (Pubitemid 29003738)
20. Simon JA, Lin F, Hulley SB, Blanche PJ, Waters D, Shiboski S, Rotter JI, Nickerson DA, Yang H, Saad M, Krauss RM 2006 Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol 97:843-850
21. Mannerås-Holm L, Leonhardt H, Kullberg J, Jennische E, Odén A, Holm G, Hellström M, Lönn L, Olivecrona G, Stener-Victorin E, Lönn M 2011 Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 96:E304-E311
22. Faulds G, Rydén M, Ek I, Wahrenberg H, Arner P 2003 Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome. J Clin Endocrinol Metab 88: 2269-2273 (Pubitemid 36549907)
23. Dicker A, Rydén M, Näslund E, Muehlen IE, Wirén M, Lafontan M, Arner P 2004 Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 47:420-428 (Pubitemid 38491238)
24. Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D 2009 Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 15:297-307
25. Rosenbaum D, Haber RS, Dunaif A 1993 Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol 264:E197-E202 (Pubitemid 23077359)
26. Corbould A, Dunaif A 2007 The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism 56:716-722 (Pubitemid 46574736)
27. Corbould A 2007 Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol 192:585-594 (Pubitemid 46455961)
28. Durchdewald M, Angel P, Hess J 2009 The transcription factor Fos: a Janus-type regulator in health and disease. Histol Histopathol 24:1451-1461
29. Patel SS, Beshay VE, Escobar JC, Carr BR 2010 17α-Hydroxylase (CYP17) expression and subsequent androstenedione production in the human ovary. Reprod Sci 17:978-986
30. Puche C, José M, Cabero A, Meseguer A 2002 Expression and enzymatic activity of the P450c17 gene in human adipose tissue. Eur J Endocrinol 146:223-229 (Pubitemid 34162915)
31. Wang Y, Fortin J, Lamba P, Bonomi M, Persani L, Roberson MS, Bernard DJ 2008 Activator protein-1 and smad proteins synergistically regulate human follicle-stimulating hormone beta-promoter activity. Endocrinology 149:5577-5591
32. Ely HA, Mellon PL, Coss D 2011 GnRH induces the c-Fos gene via phosphorylation of SRF by the calcium/calmodulin kinase II pathway. Mol Endocrinol 25:669-680
33. Xiao H, Leblanc SE, Wu Q, Konda S, Salma N, Marfella CG, Ohkawa Y, Imbalzano AN 2011 Chromatin accessibility and transcription factor binding at the PPARγ2 promoter during adipogenesis is protein kinase A-dependent. J Cell Physiol 226:86-93
34. Sharma S, Sharma PM, Mistry DS, Chang RJ, Olefsky JM, Mellon PL, Webster NJ 2011 PPARG regulates gonadotropin-releasing hormone signaling in LßT2 cells in vitro and pituitary gonadotroph function in vivo in mice. Biol Reprod 84:466-475
35. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus- Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M, Reitman ML, Vinson C 1998 Life without white fat: a transgenic mouse. Genes Dev 12:3168-3181
36. Herrera R, Ro HS, Robinson GS, Xanthopoulos KG, Spiegelman BM 1989 A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation. Mol Cell Biol 9:5331-5339
37. de Zegher F, Lopez-Bermejo A, Ibáñez L 2009 Adipose tissue expandability and the early origins of PCOS. Trends Endocrinol Metab 20:418-423
38. Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ 2006 Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:1741-1747
39. Manna PR, Dyson MT, Stocco DM 2009 Role of basic leucine zipper proteins in transcriptional regulation of the steroidogenic acute regulatory protein gene. Mol Cell Endocrinol 302:1-11
40. Zhao Y, Nichols JE, Valdez R, Mendelson CR, Simpson ER 1996 Tumor necrosis factor-α stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol Endocrinol 10:1350-1357